ProQinase Develops Novel Protein Kinase Inhibitors for Tumor Therapy
ProQinase‘s goal is to aid others in finding novel cures for cancer by focussing on protein kinases and the development of new generation protein kinase inhibitors.

ProQinase is in the top position to successfully tackle this challenge even with ongoing internal projects, because of our unique iProKiTe^® (integrated Protein Kinase Technology) Platform. ProQinase is seeking partners for discovery and development of drugs targeting protein kinases in oncology.

In a first step ProQinase and 4SC AG (Martinsried, Germany) signed in April 2003 a collaboration agreement for the joint development of protein kinase inhibitors for cancer treatment. More collaborations with companies and public research institutes have followed, see our news archive.

For learning more about our R&D efforts contact business@proqinase.com